Dear Researchers,

The library will be closed between August 10, 2026 and August 16, 2026. During this period, it will be possible to upload publications, but all other services will be suspended.

Thank you for your understanding.

Kurtán Kitti

Publication list

Tudóstér co-authors statistics filterable publication list

Export to RIS (EndNote, Mendeley, RefWorks, Zotero etc.)

Upload publications

Request certified publication list

Uploaded publications:

Publications in DEA:

OA:

Date range:

2023-2026

2026

Kovács, T., Kurtán, K., Pályi, B., Kis, Z., Mahdi, M., Borrego, J., Tőzsér, J., Varga, Z., Nagy, P., Panyi, G., Zákány, F.: The Selective DHCR24 Blocker SH42 Inhibits ACE2 Binding and Cellular Entry of SARS-CoV-2 Spike Proteins More Efficiently Than Atorvastatin.
Research. 9 (1280), 1-18, (article identifier: 1280), 2026.

doi DEA

Journal metrics:

D1 Multidisciplinary (2025)

2025

Szabó, M., Cs. Szabó, B., Kurtán, K., Varga, Z., Panyi, G., Nagy, P., Zákány, F., Kovács, T.: Look Beyond Plasma Membrane Biophysics: revealing Considerable Variability of the Dipole Potential Between Plasma and Organelle Membranes of Living Cells.
Int. J. Mol. Sci. 26 (3), 1-20, (article identifier: 889), 2025.

doi DEA WoS Scopus

Journal metrics:

Q1 Catalysis

Q1 Computer Science Applications

D1 Inorganic Chemistry

Q1 Medicine (miscellaneous)

Q2 Molecular Biology

D1 Organic Chemistry

Q1 Physical and Theoretical Chemistry

D1 Spectroscopy

2023

Kovács, T., Kurtán, K., Varga, Z., Nagy, P., Panyi, G., Zákány, F.: Veklury (remdesivir) formulations inhibit initial membrane-coupled events of SARS-CoV-2 infection due to their sulfobutylether-β-cyclodextrin content.
Br. J. Pharmacol. 180 (16), 2064-2084, 2023.

doi DEA WoS Scopus

Journal metrics:

D1 Pharmacology